Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Scientists at Schering AG describe new VEGFR-2 inhibitors and their use

Feb. 24, 2005

Two novel series of PDE7 inhibitors imparted by Daiichi Suntory

Feb. 24, 2005

Roche presents tetraazaphenalene derivatives with anticancer activity

Feb. 24, 2005

Novel 5-HT/noradrenaline reuptake inhibitors claimed by Pfizer

Feb. 24, 2005

AEgera discovers new agents for the treatment of cancer and neuronal disorders

Feb. 23, 2005

Hadasit researchers disclose a uPA-derived octapeptide for the treatment of MS

Feb. 23, 2005

The use of novel beta-secretase inhibitors for Alzheimer's disease claimed by GSK

Feb. 23, 2005

Glenmark presents novel PDE4 inhibitors for inflammatory and allergic conditions

Feb. 23, 2005

Prostaglandin D2 (DP) receptor antagonists disclosed by Merck Frosst

Feb. 23, 2005

New antibacterial monoclonal antibodies reported by Japan Science and Technology

Feb. 22, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...